322 related articles for article (PubMed ID: 2624146)
1. Differential induction of 2',5'-oligoadenylate synthetase by IFN-beta ser and IFN-alpha 2 in serum-supplemented and serum-free HL-60 leukemic cell cultures.
Fraioli M; Wu JM
J Biol Regul Homeost Agents; 1989; 3(3):112-7. PubMed ID: 2624146
[TBL] [Abstract][Full Text] [Related]
2. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
Schiller JH; Horisberger MA; Bittner G; Carlin JM; Storer B; Byrne GI; Willson JK; Borden EC
J Biol Response Mod; 1990 Aug; 9(4):368-77. PubMed ID: 2395002
[TBL] [Abstract][Full Text] [Related]
3. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
Rosenblum MG; Yung WK; Kelleher PJ; Ruzicka F; Steck PA; Borden EC
J Interferon Res; 1990 Apr; 10(2):141-51. PubMed ID: 2140395
[TBL] [Abstract][Full Text] [Related]
5. Induction of 2',5'-oligoadenylate synthetase by retinoic acid in two transformed human cell lines.
Bourgeade MF; Besançon F
Cancer Res; 1984 Nov; 44(11):5355-60. PubMed ID: 6435868
[TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of 2-5A synthetase in myeloid cells induces growth arrest and facilitates the appearance of a myeloid differentiation marker.
Salzberg S; Hyman T; Turm H; Kinar Y; Schwartz Y; Nir U; Lejbkowicz F; Huberman E
Cancer Res; 1997 Jul; 57(13):2732-40. PubMed ID: 9205084
[TBL] [Abstract][Full Text] [Related]
7. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.
Ruzicka FJ; Schmid SM; Groveman DS; Cummings KB; Borden EC
Cancer Res; 1987 Sep; 47(17):4582-9. PubMed ID: 2957045
[TBL] [Abstract][Full Text] [Related]
8. Altered cell growth and induction of an interferon-responsive gene in fibroblast lines derived from patients with familial Alzheimer's disease.
Perret V; An SJ; Wu JM
Biochem Int; 1990 Oct; 22(2):311-9. PubMed ID: 2128596
[TBL] [Abstract][Full Text] [Related]
9. Interferons-alpha/beta- and -gamma-resistant Friend cell variants exhibiting receptor sites for interferons but no induction of 2-5A synthetase and 67K protein kinase.
Coccia EM; Federico M; Romeo G; Affabris E; Cofano F; Rossi GB
J Interferon Res; 1988 Feb; 8(1):113-27. PubMed ID: 2966842
[TBL] [Abstract][Full Text] [Related]
10. Isoforms p69 and p100 of 2',5'-oligoadenylate synthetase induced differentially by interferons in vivo and in vitro.
Witt PL; Marié I; Robert N; Irizarry A; Borden EC; Hovanessian AG
J Interferon Res; 1993 Feb; 13(1):17-23. PubMed ID: 8454907
[TBL] [Abstract][Full Text] [Related]
11. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
[TBL] [Abstract][Full Text] [Related]
12. Human lung cancer nodules in organotypic culture: no evidence of correlation between the antiproliferative effects of interferons and the induction of 2',5'-oligoadenylate synthetase.
Martyré MC; Beaupain R; Falcoff E
Tumour Biol; 1988; 9(5):263-9. PubMed ID: 2461579
[TBL] [Abstract][Full Text] [Related]
13. Induction of (2'-5')oligoadenylate synthetase in serum-starved HeLa S3 cells by growth factors and its role in growth regulation.
Iwata A; Kohno M; Sokawa Y
J Biochem; 1988 Aug; 104(2):247-50. PubMed ID: 3182766
[TBL] [Abstract][Full Text] [Related]
14. 2'-5' oligo-A-synthetase activity in bovine peripheral blood leukocytes and alveolar macrophages exposed to recombinant interferons and tumor necrosis factor-alpha.
Ohmann HB; Campos M; Griebel PJ; Babiuk LA
Can J Vet Res; 1989 Apr; 53(2):161-6. PubMed ID: 2713781
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
Ferbus D; Billard C; Sigaux F; Thang MN; Falcoff E
J Biol Regul Homeost Agents; 1987; 1(3):147-53. PubMed ID: 2459906
[TBL] [Abstract][Full Text] [Related]
16. Effects of type I and II interferons on cultured human breast cells: interaction with estrogen receptors and with tamoxifen.
Goldstein D; Bushmeyer SM; Witt PL; Jordan VC; Borden EC
Cancer Res; 1989 May; 49(10):2698-702. PubMed ID: 2469536
[TBL] [Abstract][Full Text] [Related]
17. A functional protein kinase C is required for induction of 2-5A synthetase by recombinant interferon-alpha A in Daudi cells.
Faltynek CR; Princler GL; Gusella GL; Varesio L; Radzioch D
J Biol Chem; 1989 Aug; 264(24):14305-11. PubMed ID: 2474543
[TBL] [Abstract][Full Text] [Related]
18. IFN gamma potentiates the induction of (2-5)A-synthetase in human tumor cells treated with IFN alpha and beta.
Bruchelt G; Treuner J; Beck J; Schilling F; Koscielniak E; Niethammer D
Prog Clin Biol Res; 1985; 202():391-5. PubMed ID: 3938546
[No Abstract] [Full Text] [Related]
19. Pharmacokinetic study of a human recombinant interferon (Re-IFN-alpha A) in cynomolgus monkeys by 2'-5' oligoadenylate synthetase assay.
Bannai H; Tatsumi M; Kohase M; Onishi E; Yamazaki S
Jpn J Med Sci Biol; 1985 Jun; 38(3):113-24. PubMed ID: 2999483
[TBL] [Abstract][Full Text] [Related]
20. Induction of 2',5'-oligoadenylate synthetase in freshly separated malignant cells from solid tumors. Variability in the susceptibility of interferon.
Einhorn S; Vánky F; Grandér D; Willems JS
Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1607-13. PubMed ID: 2448144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
